
                           
                           
                           
                              Drug Interactions
                           
                           
                              Cyclobenzaprine may have life threatening interactions with MAO inhibitors (see ).Â Postmarketing cases of serotonin syndrome have been reported during combined use of Cyclobenzaprine Hydrochloride and other drugs, such as SSRIs, SNRIs, TCAs, tramadol, bupropion, meperidine, verapamil, or MAO inhibitors. If concomitant treatment with Cyclobenzaprine Hydrochloride and other serotonergic drugs is clinically warranted, careful observation is advised, particularly during treatment initiation or dose increases (see ).
                                            CONTRAINDICATIONS
                                 WARNINGS
                              
                              Cyclobenzaprine may enhance the effects of alcohol, barbiturates, and other CNS depressants.
                              Tricyclic antidepressants may block the antihypertensive action of guanethidine and similarly acting compounds.
                              Tricyclic antidepressants may enhance the seizure risk in patients taking tramadol.
                           
                           
                        
                     